Neurosense Therapeutics Ltd.
SEC CIK 1875091 · NRSN · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mandil-Levin Revital | Director | filed 2026 - 2026 |
| Pellizzari Christine A | Director | filed 2026 - 2026 |
| Leuchtenberger Mark | Director | filed 2026 - 2026 |
| Claiborne Cary J | Director | filed 2026 - 2026 |
| Golan Roy | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Eisenberg Or | Chief Financial Officer | filed 2026 - 2026 |
| Ben-Noon Alon | Chief Executive Officer | filed 2026 - 2026 |
| Binder Hagit | General Manager | filed 2026 - 2026 |
| Russek-Blum Niva | Chief Technology Officer | filed 2026 - 2026 |
| Tracik Ferenc | Chief Medical Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.